A European Delphi study on the management of anaemia of CKD: unmet needs in personalized treatment
European nephrologists believe that existing clinical practice guidelines are not sufficient for the management of patients with anaemia of CKD, especially in those with ESA hyporesponsiveness, infection, chronic inflammation, and malignancy. Unmet needs exist in personalized care, particularly with regard to involving patients and carers in clinical management decisions and using HRQoL tools in routine care. There are no substantial changes in the draft KDIGO 2025 guideline to adequately address the unmet needs identified here.
Authors
- Pablo Ureña‐Torres (ORCID: https://orcid.org/0000-0001-6757-1906)
- Richard Perry (ORCID: https://orcid.org/0000-0001-8790-3170)
- Roberto Minutolo (ORCID: https://orcid.org/0000-0001-5686-2089)
- Thilo Krüger
- J. Emilio Sánchez-Álvarez (ORCID: https://orcid.org/0000-0002-4431-3223)
- Indranil Dasgupta (ORCID: https://orcid.org/0000-0002-1006-4281)
- Medi Stone
- Volkan Eken
- Luis Val-Marañes
- Nathalie Heirman
- Sapna Ratan Shah (ORCID: https://orcid.org/0000-0002-3155-6357)
- Samira Bell
- J. G. Peatman
Institutions
- University of Dundee (GB)
- University of Campania "Luigi Vanvitelli" (IT)
- University of Warwick (GB)
- Adelphi Group (United Kingdom) (GB)
- GlaxoSmithKline (Belgium) (BE)
- King's College Hospital NHS Foundation Trust (GB)
- Universitätsklinikum Aachen (DE)
- University of Campania "Luigi Vanvitelli" (IT)
- NIHR Surgical Reconstruction and Microbiology Research Centre (GB)
- Hospital Universitario De Cabueñes (ES)
- Genomics (United Kingdom) (GB)
- Association pour l'Utilisation du Rein Artificiel (FR)
- Middlesex University London (GB)
- University of Birmingham (GB)
- RWTH Aachen University (DE)
Publication Details
- Journal
- Journal of Nephrology
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1007/s40620-025-02422-2
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- GlaxoSmithKline